Liu Yang, Shi Ke, Chen Yong, Wu Xianrui, Chen Zheng, Cao Ke, Tao Yongguang, Chen Xiang, Liao Junlin, Zhou Jianda
Departments of Plastic and Reconstructive Surgery, The Third Xiangya Hospital, Central South University, Changsha, China.
Department of Dermatology, The First Hospital of Changsha, Changsha, China.
Front Oncol. 2021 Mar 22;11:639159. doi: 10.3389/fonc.2021.639159. eCollection 2021.
Exosomes from extracellular vesicles can activate or inhibit various signaling pathways by transporting proteins, lipids, nucleic acids and other substances to recipient cells. In addition, exosomes are considered to be involved in the development and progression of tumors from different tissue sources in numerous ways, including remodeling of the tumor microenvironment, promoting angiogenesis, metastasis, and invasion, and regulating the immune escape of tumor cells. However, the precise molecular mechanisms by which exosomes participate in these different processes remains unclear. In this review, we describe the research progress of tumor cell-derived exosomes in cancer progression. We also discuss the prospects of the application of exosomes combined with nanoengineered chemotherapeutic drugs in the treatment of cancer.
细胞外囊泡来源的外泌体可通过将蛋白质、脂质、核酸等物质运输到受体细胞来激活或抑制各种信号通路。此外,外泌体被认为以多种方式参与不同组织来源肿瘤的发生和发展,包括重塑肿瘤微环境、促进血管生成、转移和侵袭,以及调节肿瘤细胞的免疫逃逸。然而,外泌体参与这些不同过程的确切分子机制仍不清楚。在本综述中,我们描述了肿瘤细胞来源的外泌体在癌症进展中的研究进展。我们还讨论了外泌体与纳米工程化疗药物联合应用于癌症治疗的前景。